Brief: Somalogic Reports Q2 2022 Financial Results
15/08/2022 21:16
Aug 15 (Reuters) - Somalogic Inc SLGC.O :
* SOMALOGIC REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.13
* SEES FY REVENUE $80 MILLION TO $90 MILLION
* Q2 REVENUE FELL 28.5 PERCENT TO $14.1 MILLION
Source text for Eikon: ID:nGNX4RdRCW
Further company coverage: SLGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders